Postischemic oxygen radical production varies with duration of ischemia. 1993

T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota.

Oxygen radicals have been implicated in the pathogenesis of myocardial injury. Enhanced chemiluminescence is a sensitive technique for continuous nondestructive measurement of oxygen radical generation. Using an isolated perfused rat heart model, we studied the effect of variable durations of ischemia on oxygen radical generation and postischemic myocardial function. Peak postischemic oxygen radical generation was higher with an intermediate period of ischemia (11.5 min; 528 +/- 53 counts/s) than with either a shorter period (5 min; 328 +/- 21 counts/s) or a prolonged period (40.8 min; 286 +/- 53 counts/s). The magnitude of oxygen radical generation did not correlate with postischemic mechanical function, although it was related to the duration of ischemia with regard to brief and intermediate periods of ischemia (both associated with limited mechanical damage). The increased reperfusion chemiluminescence seen with the intermediate versus the brief ischemic insults can be explained by time-dependent enhancement of the mechanisms present during ischemia that serve to increase oxygen radical generation during reperfusion. In contrast, the longer period of ischemia, resulting in severe mechanical dysfunction, was associated with lower levels of chemiluminescence than observed with an intermediate ischemic duration. This most likely results from the irreversible myocardial injury associated with prolonged ischemia and the consequent inability to generate oxygen radicals. We conclude that, although reperfusion-associated enhancement of myocardial free radical generation may be related to mild to moderate postischemic mechanical dysfunction (stunning), this mechanism may not be of importance in the generation of irreversible reperfusion myocardial injury.

UI MeSH Term Description Entries
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015425 Myocardial Reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY. Coronary Reperfusion,Reperfusion, Myocardial,Coronary Reperfusions,Myocardial Reperfusions,Reperfusion, Coronary,Reperfusions, Coronary,Reperfusions, Myocardial
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
January 2003, Anesthesiology,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
January 1991, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
June 1998, The American journal of physiology,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
June 1991, The Canadian journal of cardiology,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
April 1994, Acta anaesthesiologica Scandinavica,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
November 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
January 1982, Stroke,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
October 1996, Transplantation proceedings,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
October 1986, The Journal of trauma,
T D Henry, and S L Archer, and D Nelson, and E K Weir, and A H From
November 2020, Clinical immunology (Orlando, Fla.),
Copied contents to your clipboard!